The three main tumor markers doctors use to diagnose NSCLC are CYFRA21-1, CEA, and SCC-Ag. Additionally, research from 2018 found that a panel that includes testing for PRL, CEA, and CYFRA21-1 was ...
Serum carcinoembryonic antigen (CEA) is the most widely used tumor marker for colorectal malignancies but few studies have examined the clinical utility of CEA in patients with rectal cancer.
and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
In combination with established tumor markers, EDTA-plasma M2-PK is a useful ... M2-PK in EDTA-plasma even proves superiority as compared with CEA. Fecal Tumor M2-PK testing resembles a good ...
Atypical MTC, in which immunhistologic loss of CT or CEA or both could be demonstrated ... tumors is its thyroglobulin expression. [17] The tumor investigated in this report was completely ...
and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback